Jeffrey A Towbin Selected Research

cysteine and glycine-rich protein 3

12/2014	Disturbance in Z-disk mechanosensitive proteins induced by a persistent mutant myopalladin causes familial restrictive cardiomyopathy.
5/2006	Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
9/2003	Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey A Towbin Research Topics

Disease

35	Cardiomyopathies (Cardiomyopathy) 01/2021 - 03/2002
32	Heart Failure 01/2022 - 03/2002
28	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 03/2002
16	Long QT Syndrome 09/2016 - 01/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2003
9	Myocarditis (Carditis) 10/2021 - 02/2010
7	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022 - 02/2003
7	Sudden Death 01/2022 - 11/2002
7	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 06/2019 - 05/2002
7	Syncope (Fainting) 01/2017 - 01/2004
7	Brugada Syndrome 01/2010 - 02/2002
6	Cardiac Arrhythmias (Arrythmia) 01/2020 - 04/2008
6	Fibrosis (Cirrhosis) 01/2017 - 09/2006
6	Congenital Heart Defects (Congenital Heart Defect) 01/2016 - 09/2004
6	Aortic Coarctation 03/2011 - 09/2004
6	Aortic Valve Stenosis (Aortic Stenosis) 03/2011 - 09/2004
6	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 02/2010 - 05/2002
5	Neoplasms (Cancer) 12/2021 - 12/2012
5	Barth Syndrome 12/2012 - 05/2002
5	Hypoplastic Left Heart Syndrome 03/2011 - 09/2004
4	Restrictive Cardiomyopathy 12/2014 - 05/2002
4	Heart Arrest (Cardiac Arrest) 03/2013 - 04/2008
4	Coronary Artery Disease (Coronary Atherosclerosis) 08/2010 - 01/2004
4	Infections 08/2010 - 01/2009
4	Muscular Diseases (Myopathy) 01/2007 - 09/2002
3	Tachycardia (Tachyarrhythmias) 01/2022 - 09/2005
3	Ventricular Remodeling 12/2021 - 11/2005
3	Hypertension (High Blood Pressure) 01/2021 - 08/2013
3	Inflammation (Inflammations) 01/2020 - 08/2012
3	Ventricular Tachycardia 01/2017 - 12/2002
3	Death (Near-Death Experience) 10/2016 - 09/2006
3	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 03/2015 - 11/2005
3	Heart Diseases (Heart Disease) 06/2011 - 09/2004
3	Left Ventricular Dysfunction 07/2009 - 06/2004
3	Disease Progression 05/2007 - 12/2002
2	COVID-19 11/2021 - 01/2020
2	Myocardial Infarction 01/2021 - 10/2004
2	Low Cardiac Output 06/2019 - 03/2016
2	Pulmonary Hypertension 03/2016 - 02/2006
2	Muscular Dystrophies (Muscular Dystrophy) 04/2015 - 11/2005
2	Bradycardia 02/2014 - 01/2004
2	Shock 03/2013 - 02/2013
2	Virus Diseases (Viral Diseases) 08/2012 - 09/2004
2	Glycogen Storage Disease Type IIb 04/2010 - 01/2007
2	Hypertrophy 07/2009 - 05/2008
2	Dmd-Associated Dilated Cardiomyopathy 01/2007 - 09/2002
1	Embolic Stroke 01/2022
1	Atrial Fibrillation 01/2022

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 11/2021 - 03/2002
9	Ion Channels (Ion Channel)IBA 01/2022 - 01/2002
8	Sodium Channels (Sodium Channel)IBA 01/2010 - 02/2002
7	DystrophinIBA 04/2015 - 03/2002
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2017 - 02/2006
6	12- (4'- azido- 2'- nitrophenoxy)dodecanoyl- coenzyme AIBA 03/2011 - 09/2004
5	DNA (Deoxyribonucleic Acid)IBA 02/2010 - 04/2002
4	LipidsIBA 01/2019 - 05/2002
4	Cytoskeletal ProteinsIBA 09/2017 - 03/2002
3	Adrenergic Agents (Adrenergic Drugs)IBA 01/2022 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Desmoplakins (Desmoplakin)IBA 01/2020 - 11/2002
3	GadoliniumIBA 01/2017 - 03/2015
3	cysteine and glycine-rich protein 3IBA 12/2014 - 09/2003
3	thiazole-4-carboxamide adenine dinucleotide (TCAD)IBA 08/2010 - 11/2005
3	Cardiolipins (Cardiolipin)IBA 06/2005 - 05/2002
3	Phospholipids (Phosphatides)FDA LinkGeneric 06/2005 - 05/2002
3	Epinephrine (Adrenaline)FDA LinkGeneric 09/2004 - 06/2002
2	AnthracyclinesIBA 12/2021 - 01/2021
2	CytokinesIBA 01/2020 - 04/2003
2	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 06/2019 - 03/2016
2	Arginine Vasopressin (Argipressin)IBA 06/2019 - 06/2004
2	PeriostinIBA 01/2017 - 12/2014
2	pro-brain natriuretic peptide (1-76)IBA 01/2017 - 01/2017
2	Lamin Type A (Lamin A)IBA 11/2016 - 02/2015
2	Fas Ligand Protein (Fas Ligand)IBA 02/2016 - 01/2007
2	Biological ProductsIBA 01/2016 - 09/2009
2	Adenosine Triphosphate (ATP)IBA 02/2014 - 01/2009
2	Transcription Factors (Transcription Factor)IBA 06/2011 - 12/2008
2	AntibodiesIBA 02/2010 - 03/2002
2	SodiumIBA 09/2009 - 11/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2009 - 11/2005
2	Potassium Channels (Potassium Channel)IBA 05/2007 - 02/2002
2	gamma Catenin (Plakoglobin)IBA 09/2006 - 11/2002
2	Carrier Proteins (Binding Protein)IBA 02/2006 - 12/2005
2	Ajmaline (Wolfina)FDA Link 11/2004 - 01/2004
2	phospholipid acyltransferasesIBA 12/2003 - 05/2002
2	Ether (Diethyl Ether)IBA 07/2002 - 02/2002
1	nebulinIBA 01/2021
1	cangrelorIBA 01/2021

Therapy/Procedure

30	Therapeutics 12/2021 - 03/2002
26	Heart Transplantation (Grafting, Heart) 10/2021 - 05/2002
19	Transplantation 09/2017 - 05/2002
5	Heart-Assist Devices 01/2021 - 01/2010
5	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2017 - 05/2008
3	Defibrillators (Defibrillator) 01/2022 - 04/2006
2	Drug Therapy (Chemotherapy) 05/2021 - 01/2021
2	Catheters 03/2016 - 08/2015
2	Extracorporeal Membrane Oxygenation 06/2012 - 06/2011
1	Ablation Techniques 01/2022
1	Radiotherapy 12/2021
1	Cell Transplantation 10/2021